Trifecta Capital Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$897 Buy
14
+10
+250% +$657 ﹤0.01% 378
2026
Q1
$285 Hold
4
﹤0.01% 269
2025
Q4
$329 Sell
4
-14
-78% -$1.09K ﹤0.01% 260
2025
Q3
$1.35K Hold
18
﹤0.01% 384
2025
Q2
$1.33K Buy
18
+7
+64% +$487 ﹤0.01% 395
2025
Q1
$888 Hold
11
﹤0.01% 386
2024
Q4
$860 Hold
11
﹤0.01% 380
2024
Q3
$1.03K Hold
11
﹤0.01% 377
2024
Q2
$858 Hold
11
﹤0.01% 387
2024
Q1
$1K Hold
11
﹤0.01% 371
2023
Q4
$851 Sell
11
-483
-98% -$33.8K ﹤0.01% 406
2023
Q3
$33.6K Hold
494
0.01% 156
2023
Q2
$40.1K Buy
494
+483
+4,391% +$38.5K 0.01% 151
2023
Q1
$903 Buy
+11
New +$785 ﹤0.01% 377

Other funds holding GEHC

Trifecta Capital Advisors's GEHC Position: Q2 2026 in Review

Trifecta Capital Advisors increased its GE HealthCare (GEHC) stake by 250% in Q2 2026, buying an estimated $657 and bringing the position to 14 shares worth $897. The position accounts for ﹤0.01% of the portfolio, ranked #378.

Trifecta Capital Advisors first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $40.1K in Q2 2023. 1,229 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Trifecta Capital Advisors held 14 shares of GE HealthCare worth $897 as of Q2 2026.
  • Trifecta Capital Advisors bought 10 GE HealthCare shares in Q2 2026, an estimated $657.
  • GE HealthCare made up ﹤0.01% of Trifecta Capital Advisors's portfolio in Q2 2026, its #378 holding.
  • Trifecta Capital Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Trifecta Capital Advisors's GE HealthCare position peaked at $40.1K in Q2 2023.
  • 1,229 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Trifecta Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.